Search
for
Sort by
Research 121–150 of 1000+
- Hair disorders in patients with cancer
- TOXIC EPIDERMAL NECROLYSIS
- Hair cosmetics
- Nanotechnology-Based Cosmetics for Hair Care
- Folliculitis decalvans: Effectiveness of therapies and prognostic factors in a multicenter series of 60 patients with long-term follow-up
- Trichodysplasia of immunosuppression treated with oral valganciclovir
- Cutaneous adverse reactions linked to targeted anticancer therapies bortezomib and lenalidomide for multiple myeloma: new drugs, old side effects
- Adverse cutaneous reactions to chemotherapeutic agents and cytokine therapy
- Bioactive Molecules for Skin Repair and Regeneration: Progress and Perspectives
- REVIEW OF SO-CALLED ASEPTIC NEUTROPHILIC DERMATOSES
- A genomic approach to susceptibility and pathogenesis leads to identifying potential novel therapeutic targets in androgenetic alopecia
- LRIG1 is a positive prognostic marker in Merkel cell carcinoma and Merkel cell carcinoma expresses epithelial stem cell markers
- Clinical Development of Topoisomerase-Interactive Drugs
- Case report: pemphigus vulgaris in an adolescent
- The spectrum of nephrocutaneous diseases and associations
- Blinding in Placebo-Controlled Trials
- DERMATOLOGICAL AND SYSTEMIC REACTIONS TO HAIR DYES: CURRENT EVIDENCE AND MANAGEMENT
- Spectrum and signals of medication-associated cognitive disorder: a comprehensive disproportionality analysis with cross-database validation
- Amyopathic dermatomyositis presenting as severe alopecia and prominent eyelid edema: a case report and literature review
- Actinic Keratosis: Risk Factors, Clinical, Diagnosis and Therapeutics Aspects. Part I
- Impact of Chemotherapeutic Drug on People living with Cancer
- Plants in Hair Cosmetics
- Delayed Puberty
- Lab Quality Management and Methodology
- Dermatopathology Workshop Summary, Berlin 2004
- Main Plenary Sessions: Summaries of Papers
- Blinding in Placebo-Controlled Trials
- Cytostatics and immunosuppressive drugs
- Expanding the Nude SCID/CID Phenotype Associated with FOXN1 Homozygous, Compound Heterozygous, or Heterozygous Mutations
- Stem Cells Therapies in Basic Science and Translational Medicine: Current Status and Treatment Monitoring Strategies